What is Wegovy, and how does it work for weight loss
Keeping a symptom diary helps distinguish semaglutide-related headaches from other causes, supporting informed provider conversations
Preclinical and clinical studies have demonstrated its efficacy in reducing body weight both as a monotherapy and in combination with GLP-1 receptor agonists such as semaglutide, highlighting its potential as a next-generation therapeutic agent for obesity and metabolic syndrome management
As we age, our bodies can become deficient in key vitamins and minerals because we don't absorb them as efficiently as when we were young
Throughout this period, the favorable safety profile remained consistent with no delayed-onset adverse effects or concerning laboratory changes emerging over time
Dehydration Risk Increases GLP-1 users often: eat less drink less feel less thirsty Alcohol: increases fluid loss increases electrolyte imbalance This can lead to: headaches fatigue constipation (already common on GLP-1s) dizziness Hydration becomes much more important
)
